日本人群遗传性结直肠癌变异筛查研究
该研究对12,503例未选择的日本结直肠癌患者和23,705名对照者的27个癌症易感基因编码区进行靶向测序和全基因组SNP芯片分析,发现3.3%的患者和1.5%的对照携带致病性变异,MSH2、MLH1、MSH6、APC、BRIP1、BRCA1、BRCA2和TP53的致病性变异与结直肠癌风险显著相关。
要点
- 3.3%的未选择结直肠癌患者携带27个癌症易感基因的致病性变异。
- MSH2、MLH1、MSH6、APC、BRIP1、BRCA1、BRCA2和TP53变异与结直肠癌风险显著相关。
- 至少3.5%的日本结直肠癌人群携带致病性变异或CNV,提示遗传性癌症。
核心结论
- 在日本未选择结直肠癌患者中,3.3%携带27个癌症易感基因的致病性变异,至少3.5%携带致病性变异或CNV。
- MSH2、MLH1、MSH6、APC、BRIP1、BRCA1、BRCA2和TP53的致病性变异与结直肠癌风险显著相关(P<0.01,FDR<0.05)。
研究设计与样本
- 研究分析了12,503例未选择的日本结直肠癌患者和23,705名对照者的27个癌症易感基因编码区,采用靶向测序和全基因组SNP芯片。
- 变异临床意义依据ClinVar和ACMG/AMP指南评估。
主要发现
- 在27个基因中鉴定出4,804个变异,其中397个注释为致病性,941个为良性,43.6%为新变异。
- 3.3%的未选择结直肠癌患者和1.5%的对照携带致病性变异。
- MSH2(OR=18.1)、MLH1(OR=8.6)、MSH6(OR=4.9)、APC(OR=49.4)、BRIP1(OR=3.6)、BRCA1(OR=2.6)、BRCA2(OR=1.9)和TP53(OR=1.7)的致病性变异与结直肠癌风险显著相关(P<0.01,FDR<0.05)。
- 致病性变异与诊断年龄及个人/家族癌症史显著相关。
关键数值与推荐
- 致病性变异判定依据ClinVar和ACMG/AMP指南。
- MSH2、MLH1、MSH6、APC、BRIP1、BRCA1、BRCA2和TP53变异与结直肠癌关联的P<0.01且FDR<0.05。
临床怎么用
- 在临床中可考虑对结直肠癌患者进行多基因遗传检测,以识别遗传性癌症。
- 遗传咨询和家系筛查可能有助于高风险个体管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Colorectal cancer (CRC) is one of the most common cancers in the world. A small proportion of CRCs can be attributed to recognizable hereditary germline variants of known CRC susceptibility genes. To better understand cancer risk, it is necessary to explore the prevalence of hereditary CRC and pathogenic variants of multiple cancer-predisposing genes in non-European populations. METHODS: We analyzed the coding regions of 27 cancer-predisposing genes in 12,503 unselected Japanese CRC patients and 23,705 controls by target sequencing and genome-wide SNP chip. Their clinical significance was assessed using ClinVar and the guidelines by ACMG/AMP. RESULTS: We identified 4,804 variants in the 27 genes and annotated them as pathogenic in 397 and benign variants in 941, of which 43.6% were novel. In total, 3.3% of the unselected CRC patients and 1.5% of the controls had a pathogenic variant. The pathogenic variants of MSH2 (odds ratio (OR) = 18.1), MLH1 (OR = 8.6), MSH6 (OR = 4.9), APC (OR = 49.4), BRIP1 (OR=3.6), BRCA1 (OR = 2.6), BRCA2 (OR = 1.9), and TP53 (OR = 1.7) were significantly associated with CRC development in the Japanese population (P-values<0.01, FDR<0.05). These pathogenic variants were significantly associated with diagnosis age and personal/family history of cancer. In total, at least 3.5% of the Japanese CRC population had a pathogenic variant or CNV of the 27 cancer-predisposing genes, indicating hereditary cancers. CONCLUSIONS: This largest study of CRC heredity in Asia can contribute to the development of guidelines for genetic testing and variant interpretation for heritable CRCs.
引用
- Fujita M, Liu X, Iwasaki Y, et al. Population-based Screening for Hereditary Colorectal Cancer Variants in Japan. Clin Gastroenterol Hepatol. 2020. PMID: 33309985. doi:10.1016/j.cgh.2020.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。